All companies
Visit website
CADENCE OTC
OperatingCadence Healh, Inc.
Healthcare · Founded 2014
Birth control without barriers
Valuation cap ⓘ
$73.0M
As of Apr 2024 · from Reg CF Offering (2024) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$750,188
Across 1 round since 2024
Latest share price
$1.00
Reg CF Offering (2024) offering price
Financials
FY2021–FY2024 · from SEC filings · hover any figure for its source$0
−$3.6M
2021
$0
−$9.9M
2022
$28K
−$4.9M
2023
$1.3M
−$5.2M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$0
$27,737
$1,317,041
Cost of goods sold
$0
$0
$17,498
$574,198
Gross margin
—
—
37%
56%
Net income
-$3,634,345
-$9,919,466
-$4,860,280
-$5,201,501
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$9,781,082
$6,676,902
$4,119,343
$5,861,884
Accounts receivable
$0
$0
$27,648
$428,908
Total assets
$18,392,477
$8,959,353
$6,639,883
$8,846,562
Short-term debt
$142,391
$388,308
$568,051
$1,619,632
Long-term debt
$708,532
$708,532
$708,532
$6,846,619
Total liabilities
$850,923
$1,096,840
$1,276,583
$8,466,251
Other
Headcount
—
6
—
6
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$73.0M
Valuation cap
Reg CF Offering (2024)
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $750.2K / $3MInvestors 366Valuation cap $73M
Reg CF annual-report compliance
Delinquent
Filed 1 of 3 annual reports (FY2023–FY2025)
Missing: 2023, 2025
366 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001732157Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.